<VariationArchive VariationID="210339" VariationName="NM_001673.5(ASNS):c.478del (p.Glu160fs)" VariationType="Deletion" Accession="VCV000210339" Version="15" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2024-03-17" DateCreated="2015-10-05" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="207494" VariationID="210339">
      <GeneList>
        <Gene Symbol="ASNS" FullName="asparagine synthetase (glutamine-hydrolyzing)" GeneID="440" HGNC_ID="HGNC:753" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7q21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="97851677" stop="97928441" display_start="97851677" display_stop="97928441" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="97481428" stop="97501853" display_start="97481428" display_stop="97501853" Strand="-" />
          </Location>
          <OMIM>108370</OMIM>
        </Gene>
        <Gene Symbol="CZ1P-ASNS" FullName="CZ1P-ASNS readthrough" GeneID="107986827" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7q21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="97852117" stop="97972358" display_start="97852117" display_stop="97972358" Strand="-" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_001673.5(ASNS):c.478del (p.Glu160fs)</Name>
      <CanonicalSPDI>NC_000007.14:97864267:C:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q21.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="97864268" stop="97864268" display_start="97864268" display_stop="97864268" variantLength="1" positionVCF="97864267" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="97493580" stop="97493580" display_start="97493580" display_stop="97493580" variantLength="1" positionVCF="97493579" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>E139fs</ProteinChange>
      <ProteinChange>E160fs</ProteinChange>
      <ProteinChange>E77fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.97493580del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.97493580del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.97864268del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.97864268del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033870.2" sequenceAccession="NG_033870" sequenceVersion="2" change="g.69295del">
            <Expression>NG_033870.2:g.69295del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001352496.2" sequenceAccession="NM_001352496" sequenceVersion="2" change="c.478del">
            <Expression>NM_001352496.2:c.478del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001339425.1" sequenceAccession="NP_001339425" sequenceVersion="1" change="p.Glu160fs">
            <Expression>NP_001339425.1:p.Glu160fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_147989.1" sequenceAccession="NR_147989" sequenceVersion="1" change="n.2107del">
            <Expression>NR_147989.1:n.2107del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001673.5" sequenceAccession="NM_001673" sequenceVersion="5" change="c.478del" MANESelect="true">
            <Expression>NM_001673.5:c.478del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001664.3" sequenceAccession="NP_001664" sequenceVersion="3" change="p.Glu160fs">
            <Expression>NP_001664.3:p.Glu160fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_183356.4" sequenceAccession="NM_183356" sequenceVersion="4" change="c.478del">
            <Expression>NM_183356.4:c.478del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_899199.2" sequenceAccession="NP_899199" sequenceVersion="2" change="p.Glu160fs">
            <Expression>NP_899199.2:p.Glu160fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001178075.2" sequenceAccession="NM_001178075" sequenceVersion="2" change="c.415del">
            <Expression>NM_001178075.2:c.415del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001171546.1" sequenceAccession="NP_001171546" sequenceVersion="1" change="p.Glu139fs">
            <Expression>NP_001171546.1:p.Glu139fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001178076.2" sequenceAccession="NM_001178076" sequenceVersion="2" change="c.229del">
            <Expression>NM_001178076.2:c.229del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001171547.1" sequenceAccession="NP_001171547" sequenceVersion="1" change="p.Glu77fs">
            <Expression>NP_001171547.1:p.Glu77fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001178077.1" sequenceAccession="NM_001178077" sequenceVersion="1" change="c.229del">
            <Expression>NM_001178077.1:c.229del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001171548.1" sequenceAccession="NP_001171548" sequenceVersion="1" change="p.Glu77fs">
            <Expression>NP_001171548.1:p.Glu77fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_133436.3" sequenceAccession="NM_133436" sequenceVersion="3" change="c.478del">
            <Expression>NM_133436.3:c.478del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_597680.2" sequenceAccession="NP_597680" sequenceVersion="2" change="p.Glu160fs">
            <Expression>NP_597680.2:p.Glu160fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_133436.3" sequenceAccession="NM_133436" sequenceVersion="3" change="c.478delG">
            <Expression>NM_133436.3:c.478delG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA206838" DB="ClinGen" />
        <XRef Type="rs" ID="797045307" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001673.5(ASNS):c.478del (p.Glu160fs) AND Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome" Accession="RCV000193384" Version="11">
        <ClassifiedConditionList TraitSetID="12477">
          <ClassifiedCondition DB="MedGen" ID="C3809971">Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-04-13" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001673.5(ASNS):c.478del (p.Glu160fs) AND not provided" Accession="RCV000423550" Version="7">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-10-05" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-05" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2015-10-05" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">27422383</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30057589</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">35469797</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="12477" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18463" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ASNS DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="615574" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Asparagine synthetase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome</ElementValue>
                <XRef ID="MONDO:0014258" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ASNSD</ElementValue>
                <XRef Type="MIM" ID="615574" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17617" />
                <XRef ID="17617" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Asparagine synthetase deficiency (ASD) mainly presents as a triad of congenital microcephaly, severe developmental delay, and axial hypotonia followed by spastic quadriplegia. Low cerebrospinal fluid (CSF) asparagine level can help the clinician in differentiating this disorder from others. In most cases age of onset of apnea, excessive irritability, and seizures is soon after birth. Affected individuals typically do not acquire any developmental milestones. Spastic quadriplegia can lead to severe contractures of the limbs and neurogenic scoliosis. Feeding difficulties (gastroesophageal reflux disease, frequent vomiting, swallowing dysfunction, and gastroesophageal incoordination) are a significant problem in most affected individuals. A majority have cortical blindness. MRI findings are nonspecific but may include generalized atrophy and simplified gyral pattern.</Attribute>
                <XRef ID="NBK525916" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">30234940</ID>
                <ID Source="BookShelf">NBK525916</ID>
              </Citation>
              <XRef ID="391376" DB="Orphanet" />
              <XRef ID="C3809971" DB="MedGen" />
              <XRef ID="MONDO:0014258" DB="MONDO" />
              <XRef Type="MIM" ID="615574" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="458208" SubmissionDate="2015-09-15" DateLastUpdated="2015-10-05" DateCreated="2015-10-05">
        <ClinVarSubmissionID localKey="NM_133436.3(ASNS):c.478del|Asparagine synthetase deficiency" />
        <ClinVarAccession Accession="SCV000246574" DateUpdated="2015-10-05" DateCreated="2015-10-05" Type="SCV" Version="1" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-03-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASNS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_133436.3:c.478del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Asparagine synthetase deficiency</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="976638" SubmissionDate="2017-02-17" DateLastUpdated="2017-03-08" DateCreated="2017-03-08">
        <ClinVarSubmissionID localKey="164950830" />
        <ClinVarAccession Accession="SCV000511348" DateUpdated="2017-03-08" DateCreated="2017-03-08" Type="SCV" Version="1" SubmitterName="Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics" OrgID="505698" OrganizationCategory="clinic" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-12-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>Homo sapiens</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <NamePlatform>Illumina</NamePlatform>
              <TypePlatform>Sequencing</TypePlatform>
              <ResultType>variant call</ResultType>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="AlleleFrequency">0.000232</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="7" Strand="+" alternateAllele="-" referenceAllele="C" start="97493580" stop="97493580" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2306927" SubmissionDate="2019-10-15" DateLastUpdated="2020-03-16" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="GDX:2531267|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001168934" DateUpdated="2020-03-16" DateCreated="2020-03-16" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-11-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.478delG variant in the ASNS gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.478delG variant causes a frameshift starting with codon Glutamic Acid 160, changes this amino acid to a Lysine residue, and creates a premature Stop codon at position 8 of the new reading frame, denoted p.Glu160LysfsX8. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.478delG variant is not observed in large population cohorts (Lek et al., 2016). We interpret c.478delG as a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASNS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_133436.3:c.478delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6425168</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7343313" SubmissionDate="2023-05-17" DateLastUpdated="2023-06-03" DateCreated="2023-06-03">
        <ClinVarSubmissionID localKey="NM_133436.3:c.478delG|MedGen:C3809971" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003928688" DateUpdated="2023-06-03" DateCreated="2023-06-03" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">35469797</ID>
          </Citation>
          <Comment>Variant summary: ASNS c.478delG (p.Glu160LysfsX8) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 250206 control chromosomes. c.478delG has been reported in the literature in at least one individual affected with Asparagine Synthetase Deficiency. These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Five clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASNS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_133436.3:c.478delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3809971" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13370974</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3967523" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="8b940738204a5d8ed09cb9d32e110c1c4ffda92c6d14bf1e776cca72d4263f42|OMIM:615574" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002019540" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-03-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_133436.3:c.478del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615574" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4158647" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="13438583|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002147136" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">27422383</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30057589</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Glu160Lysfs*8) in the ASNS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ASNS are known to be pathogenic (PMID: 27422383, 30057589). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ASNS-related conditions. ClinVar contains an entry for this variant (Variation ID: 210339). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASNS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.97493580del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7343313" TraitType="Disease" MappingType="XRef" MappingValue="C3809971" MappingRef="MedGen">
        <MedGen CUI="C3809971" Name="Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3967523" TraitType="Disease" MappingType="XRef" MappingValue="615574" MappingRef="OMIM">
        <MedGen CUI="C3809971" Name="Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="458208" TraitType="Disease" MappingType="Name" MappingValue="Asparagine synthetase deficiency" MappingRef="Preferred">
        <MedGen CUI="C3809971" Name="Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="976638" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4158647" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2306927" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

